DailyUpdates for R&D News
LeadDiscovery constantly monitors the websites of Pharmaceutical and Biotech companies. Press releases relating to drug development activity are featured on DailyUpdates providing timely alerts to new clinical data, pipeline advances and regulatory news. Press releases are linked to their original source.
Latest News
- Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
- Threshold Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results of TH-302 in Patients With Pancreatic Cancer
- Takeda Announces Primary Endpoints Met for Pivotal Phase 3 Trial of VEDOLIZUMAB in Patients with Moderately to Severely Active Ulcerative Colitis Who Have Failed at Least One Conventional Therapy
- Roche\'s Zelboraf receives EU approval for the treatment of people with deadly form of skin cancer
- Curis and Debiopharm Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932 Curis and Debiopharm Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932
- Oral Treprostinil New Drug Application Accepted by FDA for Review
- CHMP Recommends Approval of BYETTAŽ for Use With Basal Insulin CHMP Recommends Approval of BYETTAŽ for Use With Basal Insulin
- BiondVax Announces Universal Flu Vaccine Improves Existing Flu Vaccines in Elderly in Second Phase II Trial
- European Commission approves CAPRELSAŽ (vandetanib) for patients with advanced medullary thyroid cancer